FrancophonIA/ELRC3.0 huggingface dataset:
English: Common (may affect up to 1 in 10 people): loss of weight, sleepiness, dizziness, tingling sensation, shortness of breath, diarrhoea, abdominal pain, upset stomach, rash, itching, hair loss, fever, weakness, shivering, feeling unwell, pain, change in taste.
Danish: Almindelig (kan påvirke op til 1 ud af 10): vægttab, søvnighed, svimmelhed, prikkende fornemmelse, kortåndethed, diarré, mavesmerter, mavetilfælde, udslæt, kløe, hårtab, feber, mathed, kulderystelser, utilpashed, smerter, ændret smagssans.
English: Uncommon (may affect up to 1 in 100 people): flu-like symptoms, red spots under the skin, low potassium level in the blood, weight gain, mood swings, hallucination and memory impairment, partial paralysis, impaired coordination, impaired sensations, partial loss of vision, dry or painful eyes, deafness, infection of the middle ear, ringing in the ears, earache, palpitations (when you can feel your heart beat), blood clot in the lung, high blood pressure, pneumonia, inflammation of your sinuses, bronchitis, a cold or flu, swollen stomach, difficulty controlling your bowel movements, haemorrhoids, peeling skin, increased skin sensitivity to sunlight, change in skin colour, increased sweating, muscle damage, back pain, difficulty in urinating, vaginal bleeding, sexual impotence, absent or heavy menstrual periods, vaginal irritation, breast pain, hot flushes, shivering, discolouration of your tongue, change in your sense of smell, thirst, tooth disorder.
Danish: Ikke almindelig (kan påvirke op til 1 ud af 100): influenza-lignende symptomer, røde pletter under huden, lavt kalium-indhold i blodet, vægtforøgelse, humørsvingninger, hallucination og hukommelsessvækkelse, delvis lammelse, koordinationsbesvær, nedsat sanseopfattelse, delvist synstab, tørre eller smertende øjne, døvhed, mellemørebetændelse, tinnitus, ørepine, hjertebanken, blodprop i lungerne, forhøjet blodtryk, lungebetændelse, bihulebetændelse, bronkitis, forkølelse eller inluenza, hævet mave, afføringsbesvær, hæmorroider, hudafskalning, øget overfølsomhed for sollys i huden, ændret hudfarve, forøget svedafsondring, muskelskade, rygsmerter, vandladningsbesvær, vaginalblødning, impotens, fraværende eller kraftig menstruation, vaginalirritation, brystsmerter, hedeture, kulderystelser, misfarvning af tungen, ændret lugtesans, tørst, tandproblemer.
English: (difficulty passing stools), nausea (feeling sick), vomiting, rash, hair loss, tiredness.
Danish: (afføringsbesvær), kvalme (utilpashed), opkastning, udslæt, hårdtab, træthed.
English: Common (may affect up to 1 in 10 people): oral infections, wound infection, reduced number of blood cells (neutropenia, thrombocytopenia, lymphopenia, leukopenia), increased sugar in the blood, loss of weight, change in mental status or alertness, anxiety/depression, sleepiness, difficulty speaking, impaired balance, dizziness, confusion, forgetfulness, difficulty concentrating, inability to fall asleep or stay asleep, tingling sensation, bruising, shaking, abnormal or blurred vision, double vision, hearing impairment, shortness of breath, cough, blood clot in the legs, fluid retention, swollen legs, diarrhoea, stomach or abdominal pain, heartburn, upset stomach, difficulty swallowing, dry mouth, skin irritation or redness, dry skin, itching, muscle weakness, painful joints, muscle aches and pains, frequent urination, difficulty with holding your urine, allergic reaction, fever, radiation injury, face swelling, pain, abnormal taste, abnormal liver function tests.
Danish: Almindelig (kan påvirke op til 1 ud af 10): infektioner i munden, sårinfektion, reduceret antal blodlegemer (neutropeni, trombocytopeni, lymfopeni, leukopeni), forøget blodsukker, vægttab, ændring i mentaltilstand eller årvågenhed, angst/depression, søvnighed, talebesvær, forringe balanceevne, svimmelhed, forvirring, glemsomhed, koncentrationsbesvær, søvnproblemer, prikkende fornemmelse, blå mærker, rystelser, unormal eller sløret syn, dobbeltsyn, høretab, kortåndethed, hoste, blodpropper i benene, væskeretention, opsvulmede ben, diarré, smerter i mave eller underliv, halsbrand, mavetilfælde, synkebesvær, tør mund, hudirritation eller rødme, tør hud, kløe, muskelsvækkelse, ledsmerter, muskelsmerter, hyppig vandladning, problemer med at holde på vandet, allergisk reaktion, feber, stråleskade, hævelse i ansigtet, smerter, unormal smagssans, unormale test af leverfunktionen.
English: Respiratory, thoracic and mediastinal disorders Common:
Danish: Luftveje, thorax og mediastinum Almindelige:
English: Propylene glycol Red iron oxide (E172) Yellow iron oxide (E172) Titanium dioxide (E171)
Danish: Propylenglycol Rød jernoxid (E172) Gul jernoxid (E172) Titaniumdioxid (E171)
English: How to take Temozolomide SUN
Danish: Sådan skal du tage Temozolomide SUN
English: Asthenia, flushing, hot flushes, condition aggravated, rigors, tongue discolouration, parosmia, thirst
Danish: Asteni, rødmen, hedestigninger, forværret tilstand, rigor, misfarvet tunge, parosmi, tørst
English: hyperbilirubinemia, cholestasis, hepatitis hepatic injury, hepatic failure†
Danish: hyperbilirubinæmi, kolestase, hepatitis, leverskade, leversvigt†
English: The cap is imprinted with ‘890'.
Danish: Hætten er påtrykt med '890'.
English: Pneumonia, upper respiratory infection, nasal congestion
Danish: Lungebetændelse, øvre luftvejsinfektion, næsetæthed
English: TMZ administration can be continued throughout the 42 day concomitant period (up to 49 days) if all of the following conditions are met:
Danish: Indgift af TMZ kan fortsættes under den konkomitante periode på 42 dage (i op til 49 dage), hvis alle de følgende betingelser er opfyldt: - absolut antal neutrofile (ANC) ≥ 1,5 x 109/l
English: What Temozolomide SUN is and what it is used for What you need to know before you take Temozolomide SUN How to take Temozolomide SUN Possible side effects
Danish: Det skal du vide, før du begynder at tage Temozolomide SUN Sådan skal du tage Temozolomide SUN Bivirkninger
English: Temozolomide SUN is administered in combination with focal radiotherapy (concomitant phase) followed by up to 6 cycles of temozolomide (TMZ) monotherapy (monotherapy phase).
Danish: Dosering Voksne med nydiagnosticeret glioblastoma multiforme Temozolomide SUN anvendes konkomitant med fokal strålebehandling (konkomitant fase) efterfulgt af op til 6 serier af temozolomid (TMZ) monoterapi (monoterapi-fase).
English: Myopathy, back pain, musculoskeletal pain, myalgia
Danish: Myopati, rygsmerte, muskuloskeletal smerte, myalgi
English: Hemiplegia, ataxia, coordination abnormal, gait abnormal, hyperesthesia, sensory disturbance
Danish: Hemiplegi, ataksi, nedsat koordinationsevne, unormal gang, hyperestesi, føleforstyrrelse
English: Dry skin, pruritus
Danish: Tør hud, kløe
English: The cap is imprinted with ‘892'.
Danish: Hætten er påtrykt med '892'.
English: Vascular disorders Common:
Danish: Vaskulære sygdomme Almindelige:
English: The cap is imprinted with ‘893'.
Danish: Hætten er påtrykt med '893'.
English: The cap is imprinted with ‘891'.
Danish: Hætten er påtrykt med '891'.
English: Cases of elevations of liver enzymes have been commonly reported.
Danish: Der er rapporteret tilfælde af forhøjede leverenzymer med hyppigheden ”almindelig”.
English: Printing ink Shellac
Danish: Tryksværte Shellak
English: Muscle weakness, arthralgia Muscle weakness, arthralgia, musculoskeletal pain, myalgia
Danish: Muskelsvaghed, artralgi, muskuloskeletal smerte, myalgi
English: Erythema, pigmentation
Danish: Myopati, rygsmerte
English: The Temozolomide SUN dose may be adjusted, delayed or stopped depending on your blood counts and how you tolerate your medicine during each treatment cycle.
Danish: Du skal igen tage Temozolomide SUN én gang dagligt i 5 dage efterfulgt af 23 dage uden Temozolomide SUN. Temozolomide SUN-dosen kan blive justeret, forsinket eller stoppet, afhængigt af din blodtælling, samt hvordan du tåler lægemidlet under hver behandlingscyklus.
English: Capsule shell Gelatin
Danish: Indhold af kapsel Lactose
English: The body is imprinted with '20 mg' and two stripes.
Danish: Kroppen er påtrykt med '20 mg' og to striber.
English: Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu/.
Danish: De kan finde yderligere oplysninger om dette lægemiddel på Det Europæiske Lægemiddelagenturs hjemmeside: http://www.ema.europa.eu/.
English: Propylene glycol Black iron oxide (E172)
Danish: Propylenglycol Sort jernoxid (E172)
English: A.
Danish: I
English: Each hard capsule contains 5 mg temozolomide.
Danish: Hver hårde kapsel indeholder 5 mg temozolomide.
English: The body is imprinted with ‘140 mg' and two stripes.
Danish: Kroppen er påtrykt med '140 mg' og to striber.
English: Each hard capsule contains 250 mg temozolomide.
Danish: Hver hårde kapsel indeholder 250 mg temozolomide.
English: The body is imprinted with ‘250 mg' and two stripes.
Danish: Kroppen er påtrykt med '250 mg' og to striber.
English: Imprint
Danish: Tryksværte
English: Temozolomide SUN 5 mg hard capsules
Danish: Temozolomide SUN 5 mg, hårde kapsler
English: - common toxicity criteria (CTC) non-haematological toxicity ≤ Grade 1 (except for alopecia, nausea and vomiting).
Danish: ikke-hæmatologisk toksicitet ≤ Grad 1 (undtagen for alopeci, kvalme, opkastning).
English: Temozolomide SUN 250 mg hard capsules
Danish: Temozolomide SUN 250 mg, hårde kapsler
English: Temozolomide SUN should be administered in the fasting state.
Danish: Temozolomid SUN hårde kapsler bør indtages fastende.
English: The body is imprinted with ‘180 mg' and two stripes.
Danish: Kroppen er påtrykt med '180 mg' og to striber.
English: Each hard capsule contains 20 mg temozolomide.
Danish: Hver hårde kapsel indeholder 20 mg temozolomide.
English: Temozolomide SUN 180 mg hard capsules
Danish: Temozolomide SUN 180 mg, hårde kapsler
English: Temozolomide SUN 140 mg hard capsules
Danish: Temozolomide SUN 140 mg, hårde kapsler
English: Each hard capsule contains 140 mg temozolomide.
Danish: Hver hårde kapsel indeholder 140 mg temozolomide.
English: Temozolomide SUN 140 mg hard capsules temozolomide
Danish: Temozolomide SUN 140 mg, hårde kapsler temozolomid
English: The body is imprinted with ‘5 mg' and two stripes.
Danish: Kroppen er præget med '5 mg' og to striber.
English: Temozolomide SUN 5 mg hard capsules temozolomide
Danish: Temozolomide SUN 5 mg, hårde kapsler temozolomid
English: Temozolomide SUN 20 mg hard capsules temozolomide
Danish: Temozolomide SUN 20 mg, hårde kapsler temozolomid
English: Vomiting, nausea, constipation
Danish: Forstoppelse, kvalme, opkastning
English: Each hard capsule contains 180 mg temozolomide.
Danish: Hver hårde kapsel indeholder 180 mg temozolomide.
English: Temozolomide SUN 250 mg hard capsules temozolomide
Danish: Temozolomide SUN 250 mg, hårde kapsler temozolomid
English: Propylene glycol Red iron oxide (E172)
Danish: Propylenglycol Rød jernoxid (E172)
English: Temozolomide SUN 20 mg hard capsules
Danish: Temozolomide SUN 20 mg, hårde kapsler
English: Posology
Danish: Dosistrin
English: Temozolomide SUN 250 mg hard capsules have a white opaque body and cap, imprinted in black ink.
Danish: Temozolomide SUN 250 mg hårde gelatinekapsler med hvidt uigennemsigtigt hætte og krop, påtrykt med sort blæk.
English: Temozolomide SUN 100 mg hard capsules
Danish: Temozolomide SUN 100 mg, hårde kapsler
English: Package Leaflet: Information for the user Temozolomide SUN 250 mg hard capsules temozolomide
Danish: Indlægsseddel: Information til brugeren Temozolomide SUN 250 mg, hårde kapsler temozolomid
English: Temozolomide SUN 20 mg hard capsules have a white opaque body and cap, imprinted in yellow ink.
Danish: Temozolomide SUN 20 mg hårde gelatinekapsler med hvidt uigennemsigtigt hætte og krop, påtrykt med gult blæk.
English: Propylene glycol Yellow iron oxide (E172)
Danish: Propylenglycol Gul jernoxid (E172)
English: Convulsions were reported very commonly in the newlydiagnosed glioblastoma multiforme patients receiving monotherapy, and rash was reported very commonly in newly-diagnosed glioblastoma multiforme patients receiving TMZ concurrent with RT and also as monotherapy, and commonly in recurrent glioma.
Danish: Hos patienter med nyligt diagnosticeret glioblastom multiforme, der fik TMZ samtidig med strålebehandling eller som monoterapi, blev udslæt rapporteret som værende meget almindeligt.
English: Temozolomide SUN 5 mg hard capsules have a white opaque body and cap, imprinted in green ink.
Danish: Temozolomide SUN 5 mg hårde gelatinekapsler med hvid, uigennemsigtig hætte og krop, påtrykt med grønt blæk.
English: Each hard capsule contains 100 mg temozolomide.
Danish: Hver hårde kapsel indeholder 100 mg temozolomide.
English: Temozolomide SUN 140 mg hard capsules have a white opaque body and cap, imprinted in blue ink.
Danish: Temozolomide SUN 140 mg hårde gelatinekapsler med hvidt uigennemsigtigt hætte og krop, påtrykt med blåt blæk.
English: Stomatitis, diarrhoea,
Danish: Diarré, mavesmerte, dyspepsi
English: Package Leaflet: Information for the user Temozolomide SUN 20 mg hard capsules temozolomide
Danish: Indlægsseddel: Information til brugeren Temozolomide SUN 20 mg, hårde kapsler temozolomid
English: Temozolomide SUN 180 mg hard capsules temozolomide
Danish: Temozolomide SUN 180 mg, hårde kapsler temozolomid
English: The body is imprinted with ‘100 mg' and two stripes.
Danish: Kroppen er påtrykt med '100 mg' og to striber.
English: Temozolomide SUN 100 mg hard capsules temozolomide
Danish: Temozolomide SUN 100 mg, hårde kapsler temozolomid
English: constipation, anorexia, headache and fatigue.
Danish: Bivirkningerne er som følger: kvalme, opkastning, forstoppelse, anoreksi, hovedpine og træthed.
English: Package Leaflet: Information for the user Temozolomide SUN 5 mg hard capsules temozolomide
Danish: Indlægsseddel: Information til brugeren Temozolomide SUN 5 mg, hårde kapsler temozolomid
English: Package Leaflet: Information for the user Temozolomide SUN 140 mg hard capsules temozolomide
Danish: Indlægsseddel: Information til brugeren Temozolomide SUN 140 mg, hårde kapsler temozolomid
English: Package Leaflet: Information for the user Temozolomide SUN 180 mg hard capsules temozolomide
Danish: Indlægsseddel: Information til brugeren Temozolomide SUN 180 mg, hårde kapsler temozolomid
English: Temozolomide SUN 100 mg hard capsules have a white opaque body and cap, imprinted in pink ink.
Danish: Temozolomide SUN 100 mg hårde gelatinekapsler med hvidt uigennemsigtigt hætte og krop, påtrykt med lyserødt blæk.
English: - The other ingredients are: capsule content: lactose, sodium starch glycolate (Type B), tartaric acid, stearic acid (see section 2 "Temozolomide SUN contains lactose") capsule shell: gelatin, titanium dioxide (E171), sodium laurilsulfate printing ink: shellac, propylene glycol, titanium dioxide (E171), blue #1/Brilliant Blue FCF Aluminium Lake (E133).
Danish: Kapselskal: gelatine, titaniumdioxid (E171), natriumlaurilsulfat Tryksværte: shellak, propylenglycol, titaniumdioxid (E171), blå 1/Brilliant Blue FCF aluminium lake (E 133).
English: Hard gelatin capsule, with white opaque cap and body, imprinted in yellow ink.
Danish: Hård gelatinekapsel med hvid, uigennemsigtig hætte og krop, påtrykt med gult blæk.
English: Temozolomide SUN 180 mg hard capsules have a white opaque body and cap, imprinted in red ink.
Danish: Temozolomide SUN 180 mg hårde gelatinekapsler med hvidt uigennemsigtigt hætte og krop, påtrykt med rødt blæk.
English: Eye disorders Common:
Danish: Øjne Almindelige:
English: - The other ingredients are: capsule content: lactose, sodium starch glycolate (Type B), tartaric acid, stearic acid (see section 2 "Temozolomide SUN contains lactose") capsule shell: gelatin, titanium dioxide (E171), sodium laurilsulfate printing ink: shellac, propylene glycol, red iron oxide (E172), yellow iron oxide (E172), titanium dioxide (E171).
Danish: Kapselskal: gelatine, titaniumdioxid (E171), natriumlaurilsulfat Tryksværte: shellak, propylenglycol, rød jernoxid (E172), gul jernoxid (E172), titaniumdioxid (E171).
English: If you take more Temozolomide SUN than you should
Danish: Hvis du har taget for meget Temozolomide SUN
English: In patients treated with TMZ, whether used in combination with RT or as monotherapy following RT for newly-diagnosed glioblastoma multiforme, or as monotherapy in patients with recurrent or progressive glioma, the reported very common adverse reactions were similar: nausea, vomiting,
Danish: Dette er gældende for patienter med nyligt diagnosticeret glioblastom multiforme, der behandles i kombination med strålebehandling, eller som behandles med monoterapi efterfulgt af strålebehandling, samt for patienter med recidiv eller progressivt gliom, der behandles med monoterapi.
English: Package Leaflet: Information for the user Temozolomide SUN 100 mg hard capsules temozolomide
Danish: Indlægsseddel: Information til brugeren Temozolomide SUN 100 mg, hårde kapsler temozolomid
English: - The other ingredients are: capsule content: lactose, sodium starch glycolate (Type B), tartaric acid, stearic acid (see section 2 "Temozolomide SUN contains lactose") capsule shell: gelatin, titanium dioxide (E171), sodium laurilsulfate printing ink: shellac, propylene glycol, yellow iron oxide (E172), blue #1/Brilliant Blue FCF Aluminium Lake (E133).
Danish: Kapselskal: gelatine, titaniumdioxid (E171), natriumlaurilsulfat Tryksværte: shellak, propylenglycol, gul jernoxid (E172), blå 1/Brilliant Blue FCF aluminium lake (E 133).
English: EU/1/11/697/017 (5 hard capsules) EU/1/11/697/018 (20 hard capsules)
Danish: EU/1/11/697/017 (5 hårde kapsler) EU/1/11/697/018 (20 hårde kapsler)
English: Treatment-emergent events during concomitant and monotherapy treatment phases in patients with newly-diagnosed glioblastoma multiforme System organ class
Danish: Bivirkninger fremkommet hos patienter med ny diagnosticeret glioblastoma multiforme under konkomitant- og monoterapi-behandlingsfaserne
English: Hard gelatin capsules, with white opaque cap and body, imprinted in red ink.
Danish: Hårde gelatinekapsler med hvid, uigennemsigtig hætte og krop, påtrykt med rødt blæk.
English: Very common:
Danish: Almindelige:
English: Hard gelatin capsules, with white opaque cap and body, imprinted in black ink.
Danish: Hårde gelatinekapsler med hvid, uigennemsigtig hætte og krop, påtrykt med sort blæk.
English: Gastrointestinal disorders Very common:
Danish: Mave-tarm-kanalen Meget almindelige:
English: Hearing impairment
Danish: Sløret syn
English: EU/1/11/697/017 (5 capsules in blister) EU/1/11/697/018 (20 capsules in blister)
Danish: EU/1/11/697/017 (5 kapsler i blisterpakke) EU/1/11/697/018 (20 kapsler i blisterpakke)
English: EU/1/11/697/023 (5 hard capsules) EU/1/11/697/024 (20 hard capsules)
Danish: EU/1/11/697/023 (5 hårde kapsler) EU/1/11/697/024 (20 hårde kapsler)
English: Hard gelatin capsules, with white opaque cap and body, imprinted in blue ink.
Danish: Hårde gelatinekapsler med hvid, uigennemsigtig hætte og krop, påtrykt med blåt blæk.
English: EU/1/11/697/015 (5 hard capsules) EU/1/11/697/016 (20 hard capsules)
Danish: EU/1/11/697/015 (5 hårde kapsler) EU/1/11/697/016 (20 hårde kapsler)
English: Otitis media, tinnitus, hyperacusis, earache
Danish: Mellemørebetændelse, tinnitus, lydoverfølsomhed, ørepine
English: Hard gelatin capsules, with white opaque cap and body, imprinted in green ink.
Danish: Hårde gelatinekapsler med hvid, uigennemsigtig hætte og krop, påtrykt med grønt blæk.
English: EU/1/11/697/019 (5 hard capsules) EU/1/11/697/020 (20 hard capsules)
Danish: EU/1/11/697/019 (5 hårde kapsler) EU/1/11/697/020 (20 hårde kapsler)
English: EU/1/11/697/023 (5 capsules in blister) EU/1/11/697/024 (20 capsules in blister)
Danish: EU/1/11/697/023 (5 kapsler i blisterpakke) EU/1/11/697/024 (20 kapsler i blisterpakke)
English: EU/1/11/697/013 (5 hard capsules) EU/1/11/697/014 (20 hard capsules)
Danish: EU/1/11/697/013 (5 hårde kapsler) EU/1/11/697/014 (20 hårde kapsler)
English: EU/1/11/697/015 (5 capsules in blister) EU/1/11/697/016 (20 capsules in blister)
Danish: EU/1/11/697/015 (5 kapsler i blisterpakke) EU/1/11/697/016 (20 kapsler i blisterpakke)
English: EU/1/11/697/021 (5 capsules in blister) EU/1/11/697/022 (20 capsules in blister)
Danish: EU/1/11/697/021 (5 kapsler i blisterpakke) EU/1/11/697/022 (20 kapsler i blisterpakke)
English: EU/1/11/697/013 (5 capsules in blister) EU/1/11/697/014 (20 capsules in blister)
Danish: EU/1/11/697/013 (5 kapsler i blisterpakke) EU/1/11/697/014 (20 kapsler i blisterpakke)
English: EU/1/11/697/021 (5 hard capsules) EU/1/11/697/022 (20 hard capsules)
Danish: EU/1/11/697/021 (5 hårde kapsler) EU/1/11/697/022 (20 hårde kapsler)
English: EU/1/11/697/019 (5 capsules in blister) EU/1/11/697/020 (20 capsules in blister
Danish: EU/1/11/697/019 (5 kapsler i blisterpakke) EU/1/11/697/020 (20 kapsler i blisterpakke)
English: Hemiparesis, aphasia, balance
Danish: Hyperglycæmi, vægttab
English: Hard gelatin capsules, with white opaque cap and body, imprinted in pink ink.
Danish: Hårde gelatinekapsler med hvid, uigennemsigtig hætte og krop, påtrykt med lyserødt blæk.
English: Musculoskeletal and connective tissue disorders Common:
Danish: Knogler, led, muskler og bindevæv Almindelige:
English: ATCvet code: QI06AJ05.
Danish: ATCvet-kode: QI06AJ05.
English: The reaction was transient.
Danish: Reaktionen var forbigående.
English: Date of first authorisation: 23/02/2005 Date of last renewal: 15/01/2010
Danish: Dato for første markedsføringstilladelse: 23/02/2005 Dato for seneste fornyelse af markedsføringstilladelsen: 15/01/2010
English: Vaccination of FeLV positive cats is of no benefit.
Danish: Vaccination af FeLV positive dyr er ikke tilrådeligt.
English: 2 egg infective dose 50%.
Danish: 2 æg infektiøs dosis 50%.
English: Safety and efficacy data are available which demonstrate that this vaccine can be administered the same day but not mixed with Merial adjuvanted vaccine against rabies.
Danish: Der foreligger oplysninger om sikkerhed og virkning der viser, at denne vaccine kan anvendes den samme dag men ikke blandes med Merials vaccine med adjuvans mod rabies.
English: Laboratoire Porte des Alpes Rue de l'Aviation
Danish: Laboratoires Porte des Alpes Rue de l'Aviation
English: Primary vaccination course: - first injection: from 8 weeks of age, - second injection: 3 to 4 weeks later.
Danish: Basisvaccination: - første injektion fra 8 ugersalderen, - anden injektion: 3-4 uger senere.
English: * less than 1 animal in 10,000 animals displaying adverse reaction(s) during the course of one treatment, including isolated reports.
Danish: * mindre end 1 dyr ud af 10.000 dyr, der viser bivirkninger i løbet af en behandling, herunder isolerede rapporter.
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment) - common (more than 1 but less than 10 animals in 100 animals) - uncommon (more than 1 but less than 10 animals in 1,000 animals ) - rare (more than 1 but less than 10 animals in 10,000 animals) - very rare (less than 1 animal in 10,000 animals, including isolated reports).
Danish: Hyppigheden af bivirkninger er defineret som: - Meget almindelig (mere end 1 ud af 10 dyr, der viser bivirkninger i løbet af en behandling) - Almindelige (mere end 1, men mindre end 10 dyr i 100 dyr) - Ualmindelige (mere end 1, men mindre end 10 dyr i 1.000 dyr) - jældne (mere end 1, men mindre end 10 dyr ud af 10.000 dyr) - Meget sjælden (mindre end 1 dyr ud af 10.000 dyr, herunder isolerede rapporter)
English: As a consequence, the vaccine induces an immune status against feline leukaemia virus.
Danish: Som en følge heraf inducerer vaccinen immunstatus over for felin leukæmivirus.
English: Do not mix with any other veterinary medicinal product, except the solvent supplied for use with the product.
Danish: Må ikke blandes med lægemidler til dyr undtaget den solvens, der leveres til brug med dette produkt.
English: EU/2/04/047/001 lyophilisate (10 bottles of 1 dose) + solvent (10 bottles of 1 ml) EU/2/04/047/002 lyophilisate (50 bottles of 1 dose) + solvent (50 bottles of 1 ml)
Danish: EU/2/04/047/001 Lyofilisat (10 flasker à 1 dosis) + solvens (10 flasker à 1 ml) EU/2/04/047/002 Lyofilisat (50 flasker à 1 dosis) + solvens (50 flasker à 1 ml)